Patents Assigned to Prime Bio, Inc
  • Patent number: 12528843
    Abstract: Present invention relates to a pharmaceutical composition comprising P80 with drugs, dyes, small molecules, biomolecules, proteins or combination thereof. P80 enhances the transportation of molecules associated with it. The P80 is a tight junction modulators to enhance the permeability of the intestinal epithelium so as to facilitate drug delivery. The invention further provides a process for the preparation, isolation and purification of p80 protein.
    Type: Grant
    Filed: September 17, 2020
    Date of Patent: January 20, 2026
    Assignee: Prime Bio, Inc
    Inventors: Bal Ram Singh, Raj Kumar
  • Publication number: 20220081473
    Abstract: Present invention relates to a pharmaceutical composition comprising P80 with drugs, dyes, small molecules, biomolecules, proteins or combination thereof. P80 enhances the transportation of molecules associated with it. The P80 is a tight junction modulators to enhance the permeability of the intestinal epithelium so as to facilitate drug delivery. The invention further provides a process for the preparation, isolation and purification of p80 protein.
    Type: Application
    Filed: September 17, 2020
    Publication date: March 17, 2022
    Applicant: Prime Bio, Inc
    Inventors: Bal Ram Singh, Raj Kumar
  • Patent number: 11040090
    Abstract: Present invention provides a stable pharmaceutical composition comprising botulinum neurotoxin, anesthetic in a buffer. Present invention also provides a process for the preparation of the stable pharmaceutical composition. The botulinum neurotoxin is stabilized by the formation of complex between the toxin and anesthetic. The present invention further provides a method for treating wrinkles using the said pharmaceutical composition.
    Type: Grant
    Filed: December 8, 2016
    Date of Patent: June 22, 2021
    Assignee: Prime Bio, Inc
    Inventor: Bal Ram Singh
  • Publication number: 20180161406
    Abstract: Present invention provides a stable pharmaceutical composition comprising botulinum neurotoxin, anesthetic in a buffer. Present invention also provides a process for the preparation of the stable pharmaceutical composition. The botulinum neurotoxin is stabilized by the formation of complex between the toxin and anesthetic. The present invention further provides a method for treating wrinkles using the said pharmaceutical composition.
    Type: Application
    Filed: December 8, 2016
    Publication date: June 14, 2018
    Applicant: Prime Bio, Inc
    Inventor: Bal Ram Singh
  • Publication number: 20180147223
    Abstract: Present invention discloses a method of treating an individual suffering from botulism by inhibiting botulinum neurotoxins.
    Type: Application
    Filed: November 29, 2016
    Publication date: May 31, 2018
    Applicant: Prime Bio, Inc
    Inventors: Bal Ram Singh, Kruti Patel